Private Advisor Group, LLC Alnylam Pharmaceuticals, Inc. Transaction History

Private Advisor Group, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 13, 2022	SELL	$120.42 - $169.29 $181,232 - $254,781	-1,505 Reduced 43.35%	1,967 $287,000
Q1 2022 May 12, 2022	SELL	$127.18 - $173.91 $44,894 - $61,390	-353 Reduced 9.23%	3,472 $567,000
Q4 2021 Feb 10, 2022	SELL	$159.56 - $209.29 $183,334 - $240,474	-1,149 Reduced 23.1%	3,825 $649,000
Q3 2021 Oct 14, 2021	BUY	$169.75 - $207.73 $466,812 - $571,257	2,750 Added 123.65%	4,974 $940,000
Q2 2021 Aug 12, 2021	BUY	$128.63 - $176.89 $101,360 - $139,389	788 Added 54.87%	2,224 $377,000
Q1 2021 Apr 22, 2021	BUY	$126.83 - $175.69 $182,127 - $252,290	1,436 New	1,436 $203,000
Q3 2020 Nov 02, 2020	SELL	$121.19 - $165.49 $83,984 - $114,684	-693 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$104.21 - $156.44 $72,217 - $108,412	693 New	693 $103,000

644

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Advisor Group, LLC with notifications on news.